Sage Journals: Discover world-class research

Open access

Review article

First published 2019

Switching from infliximab to biosimilar in inflammatory bowel disease: overview of the literature and perspective

Ágnes Milassin, Anna Fábián, Tamás Molnár

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2025

Switch acceptance and persistence of adalimumab biosimilars in IBD patients: a prospective observational study

Gabrielle D’Abbundo, Maria Nachury, Alice Wartski [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2025-4

Persistence After Switching From Adalimumab Biosimilar MSB11022 to Adalimumab Biosimilar GP2017 in Patients With Chronic Inflammatory Rheumatic Diseases

Joaquín Borrás-Blasco, Alejandro Valcuende-Rosique, Silvia Cornejo [...]

Journal of Pharmacy Technology

Open access

Research article

First published 2022

Effectiveness and safety of a biosimilar-to-biosimilar switch of the TNF inhibitor etanercept in patients with chronic inflammatory rheumatic diseases

Uta Kiltz, Styliani Tsiami, Xenofon Baraliakos [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Research article

First published 2024

Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study

Sarah Fischer, Moritz Donhauser, Sarah Cohnen [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2018

Switching from originator infliximab to the biosimilar CT-P13 in 313 patients with inflammatory bowel disease

Viktoria Bergqvist, Mohammad Kadivar, Daniel Molin [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2024

Counting the costs: a nationwide study on healthcare use following an adalimumab biosimilar switch in >1300 inflammatory arthritis patients

Hafsah Nabi, Rikke Ibsen, Michael Ibsen [...]

Therapeutic Advances in Musculoskeletal Disease

Retricted access

Research article

First published 2023-11

Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

Ashish Sharma, Anat Loewenstein, Nikulaa Parachuri [...]

Journal of VitreoRetinal Diseases

Open access

Research article

First published 2021

Long-term effectiveness,safety and immunogenicity of the biosimilar SB2 in inflammatory bowel disease patients after switching from originator infliximab

Sarah Fischer, Sarah Cohnen, Entcho Klenske [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2026

Navigating biosimilar transitions in IV rituximab therapy: Efficacy and safety insights from a real-world switching study

Abdülkadir Erçalışkan, Duygu Seyhan Erdoğan, Furkan Bahar [...]

Journal of Oncology Pharmacy Practice

Search results